Description: This is the SOA website page displaying the table of contents for Risk Management: The Current Financial Crisis, Lessons Learned and Future Implications series of essays.

Description: Have you heard of Prospect Theory, the Nobel-winning concept from psychologists Kahneman and Tversky, which is the inspiration for much of behavioral economics? Come examine this concept that focuses on how people sometimes make irrational and logically inconsistent decisions depending on the framing of the question. You'll also explore how Prospect Theory applies in the world of insurance and how it offers an explanation for why selling retirement income products is more challenging than selling life insurance. Leave this session with ideas on how to design and market retirement income products that are likely to be more successful. The presentation will be largely based upon this paper: https://www.soa.org/sections/joint-risk-mgmt/joint-risk-mgmt-newsletter/2023/february/rm-2023-02-reynolds/

Description: Behavioral economics research has shown that small details can have a large impact on how a person behaves. As life insurance continues its evolution into the digital domain, life insurers now have an almost infinite number of ways to tweak their product offering, positioning, and delivery to the end consumer. Behavioral science is becoming increasingly more important to optimize these product design decisions and improve outcomes for both insurers and their customers. Discover a brief overview of key behavioral economic concepts and dive into two SOA research projects that are exploring how behavioral economic techniques can be used in different parts of the life insurance value chain. First, you'll start before a policy is even sold, by exploring how behavioral economics, through techniques such as the messenger effect, can be used to increase consumers' comprehension of policies and life insurance's value. Second, you'll look at how underwriting question design can impact applicant behavior and lead to higher quality application data. At the conclusion, you'll enjoy having a better understanding of how behavioral economic techniques can be applied in a life insurance context.

Description: This SOA e-course shows you how to use financial modeling to assess or mitigate risk. It covers derivatives pricing, range of outcomes and more.

Description: This paper highlights the impact on shareholder equity and AOCI due to the introduction of LDTI during a period of falling interest rates. The paper is intended to provide an example of an analysis that will help actuaries explain the interaction of LDTI and falling interest rates.

Description: First from a comparison of U.S. and Japanese interest rates, abrupt switch to sumo, because sumo is life! Okay, it is not -- in March 2022, there was an upset win when a tall but li wrestler won the tournament. Just as in sumo, when it's not the more massive man who wins, we need to question our assumptions in our models.

Description: Many drugs, like the immunologic drugs used to treat inflammatory and oncologic conditions, are FDA-authorized to treat more than one condition. Given different conditions have varying clinical outcomes and costs, it is likely the same drug provides a range of value across multiple conditions. However, such drugs have traditionally had a single list price and corresponding payer net cost. Indication-based pricing and benefit design (IBPBD) is intended to address the variable clinical and economic value for the same drug across multiple treatment indications. As this trend continues to evolve, the determination of drug value by treatment indication will create risks and/or opportunities in pharmacy benefit design, ultimately impacting pharmacy PMPM forecasting and incurred costs. Learn from faculty as they: Provide the business context for IBPBD. Describe varying structural approaches. Discuss the market conditions that can motivate or demotivate payers. Explore operational barriers. Recommend a role for actuaries. To bring the discussion to life, a case study will be reviewed. By attending the session, you will be able to: • Describe the meaning of Indication-Based Drug Pricing and Benefit Design (IDPBD). • Understand the risks and opportunities with IBPBD. • Articulate the advantages and disadvantages of distinguishing the value of a drug by treatment indications.

Description: The Academy Economic Scenario Generator is set to be replaced by a new ESG created in a partnership between the NAIC and Conning. This summer, we will present three separate webinars that will investigate the key features of the new ESG, examine the process through which it was created, and discuss what it all means for actuaries impacted by the change.

Description: Given the rise in interest rates during 2022, explore the implications of increasing rates on FA and FIA business by looking at industry experience for FA and FIA products for 2022 compared to earlier years. Additionally, come walk through partial withdrawals, GLWB utilization, mortality and what to expect as interest rate volatility continues. You'll also discover how direct writers and reinsurers are handing the in-force management aspects of these products in the uncertain and volatile economic periods. Key learning outcomes include: - Understand the impact of rising rates on dynamic lapse for FA and FIA products - Explanation ofin-force management actions that are being taken in the current interest rate environment - Be informed of current trends in GLWB utilization